Trametinib
Trametinib is an ATP-noncompetitive inhibitor of MEK 1/2 (IC50s: 0.7/0.9 nM). It shows low inhibition for more than 180 kinases, including B-Raf, c-Raf, and MEK5.

Catalog Number | T2125 |
Alternative Name(s) | GSK1120212 , JTP-74057 |
Research Area | MAPK|||Autophagy|||Apoptosis |
Molecular Formula | C26H23FIN5O4 |
CAS# | 871700-17-3 |
Purity | 99.88% |
SMILES | CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O |
Size | 200 mg |
Supplier Page | https://www.targetmol.com/compound/Trametinib |
Additional Information | https://www.targetmol.com/datasheet/T2125 |